Skip to Content

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing multimodal disease-modifying therapies for viral, neuropathic and neurodegenerative diseases. The company’s current pipeline consists of three therapeutic programs targeting COVID-19, pain indications and Alzheimer’s disease.